Aggregate Cost of Mammography Screening in the United States
Authors: John D. Keen
Journal: Annals of Internal Medicine (2014)

Letters19 August 2014Aggregate Cost of Mammography Screening in the United StatesJohn D. Keen, MD, MBAJohn D. Keen, MD, MBAFrom John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L14-5016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:O'Donoghue and colleagues (1) have conservatively estimated the aggregate cost of screening mammography in the United States under several scenarios. Screening advocates will argue that the number of lives extended under an aggressive annual screening scenario differs from that under the U.S. Preventive Services Task Force (USPSTF) guidelines. Although the authors cite a cost-effectiveness ratio of annual screening compared with biennial screening of more than $340 000 per quality-adjusted life-year, the real ratio—including indirect costs and overdiagnosis—is probably double or triple that estimate (2).Furthermore, Hubbard and associates (3) have shown that annual screening in the United States ...References1. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med. 2014;160:145-53. [PMID: 24658691] doi:10.7326/M13-1217 LinkGoogle Scholar2. Keen JD. Analysis of health benefits and cost-effectiveness of mammography for breast cancer [Letter]. Ann Intern Med. 2011;155:566. [PMID: 22007057] doi:10.7326/0003-4819-155-8-201110180-00028 LinkGoogle Scholar3. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155:481-92. [PMID: 22007042] doi:10.7326/0003-4819-155-8-201110180-00004 LinkGoogle Scholar4. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998-2005. [PMID: 23171096] doi:10.1056/NEJMoa1206809 CrossrefMedlineGoogle Scholar5. Keen JD. The ACR/SBI breast cancer screening guidelines are wrong. Medscape Radiology. 2 March 2012. Accessed at www.medscape.com/viewarticle/759429 on 6 February 2014. Google Scholar Author, Article, and Disclosure InformationAffiliations: From John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L14-0174. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAggregate Cost of Mammography Screening in the United States: Comparison of Current Practice and Advocated Guidelines Cristina O'Donoghue , Martin Eklund , Elissa M. Ozanne , and Laura J. Esserman Aggregate Cost of Mammography Screening in the United States Mark A. Helvie Aggregate Cost of Mammography Screening in the United States Martin Eklund , Cristina O'Donoghue , and Laura J. Esserman Aggregate Cost of Mammography Screening in the United States Martin Eklund , Cristina O'Donoghue , and Laura J. Esserman Aggregate Cost of Mammography Screening in the United States Mark A. Helvie Metrics 19 August 2014Volume 161, Issue 4Page: 304KeywordsCancer screeningConflicts of interestDiagnostic imagingDisclosureFallsMammographyRadiologistsSurgeons ePublished: 19 August 2014 Issue Published: 19 August 2014 CopyrightCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...